Advertisement

Topics

Lilly Corporate Center Company Profile

02:01 EDT 24th October 2017 | BioPortfolio

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem™ technology platform to the full range of <!--LGfEGNT2Lhm-->protein therapeutic candidates including antibodies, cytokines, hormones and enzymes to develop novel human biotherapeutic candidates.
Since February 2004, AME has been a wholly-owned subsidiary of <!--LGfEGNT2Lhm-->Eli Lilly and Company and is an integral part of Lilly’s research organization. Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

While geographically separate, AME works closely with Lilly colleagues in Indianapolis and around the world, sharing a corporate legacy of integrity and commitment to quality that spans more than a century.

 

Lilly(TM) is a registered trademark of Eli Lilly and Company.  BioPortfolio's use of the Lilly(TM) trademark on this site does not imply any affiliation with or endorsement by Eli Lilly and Company.  If you are looking for Eli Lilly and Company's official website, please visit www.lilly.com.

Location

Mail Drop Code 1854
Indianapolis
Indiana
46285
United States of America

Contact

Phone: 317-276-2790
Fax: 317-276-4878


News Articles [958 Associated News Articles listed on BioPortfolio]

Eli Lilly opens expanded biotechnology center in San Diego

Eli Lilly and Company has announced completion of a $90 million expansion of its Biotechnology Center in San Diego, California. Lilly's new space will help foster and accelerate the discovery of medic...

Lilly Announces Plans to Close its Shanghai R&D Center

In a letter to China employees, Andrew Hodge, President, Lilly China, notified staff members that Lilly will close down its Shanghai R&D center. The center opened in 2012 and is located in Zhangji...

Eli Lilly completes $90m expansion of biotechnology center in San Diego

Eli Lilly and Company has completed the $90m expansion of its biotechnology center in San Diego, California, US.

Lilly Adds Chemistry Capabilities in San Diego Lab Expansion

Eli Lilly (NYSE: LLY) has completed a $90 million expansion of its biotechnology R&D center in San Diego, added new automated synthesis equipment, and plans to build out its next-generation chemis...

Lilly Completes $90M Expansion of San Diego Biotechnology Center

Eli Lilly has added a new state-of-the-art laboratory and 180,000 square feet of additional working space to its Biotechnology Center in San Diego, CA. Reporting completion of the $90-million expansio...

Eli Lilly to Eliminate 3,500 Jobs; Close Shanghai, N.J. R&D Operations

Eli Lilly said this morning it will eliminate 8% of its workforce—approximately 3,500 jobs—through a restructuring designed to cut costs and further focus the company on developing new treatments....

Eli Lilly to Eliminate 3500 Jobs; Close Shanghai, New Jersey R&D Operations

Eli Lilly said this morning it will eliminate 8% of its workforce—approximately 3500 jobs—through a restructuring designed to cut costs and further focus the company on developing new treatments. ...

Drugmaker Lilly beats Street 2Q forecasts, raises outlook

This Tuesday, July 17, 2012, file photo shows the Eli Lilly corporate headquarters in Indianapolis. Eli Lilly and Co.

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Indiana Oxygen Company, Inc.]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

PubMed Articles [478 Associated PubMed Articles listed on BioPortfolio]

Comparison of the Center and Flex-Center Methods of Corneal Endothelial Cell Analysis in the Presence of Guttae.

To compare endothelial cell analysis by the center and flex-center methods in corneas with guttae of differing severity and to determine the minimum countable cell number for using only the flex-cente...

Elisa Gordon, PhD, MPH: Professor, Comprehensive Transplant Center, Department of Surgery; Center for Healthcare Studies, Institute for Public Health and Medicine; and Center for Bioethics and Medical Humanities, Department of Medical Education, Feinberg School of Medicine, Northwestern University, Chicago, IL.

Impact of a Cleft and Craniofacial Center on an Academic Health System.

The contributions of all physician specialties and ancillary services involved in cleft and craniofacial center care must be evaluated to fairly assess the financial impact of a cleft and craniofacial...

Positive Impact of an Aortic Center Designation.

In January 2015 we created a multidisciplinary Aortic Center with the collaboration of Vascular Surgery, Cardiac Surgery, Interventional Radiology, Anesthesia and Hospital Administration. We report th...

A precisely positioned chiral center in an i, i + 7 tether modulates the helicity of the backbone peptide.

In some cases, helical peptides stabilized by an i, i + 7 tether exhibit better target binding and cellular functions compared to their i, i + 4 analogues. Herein, we carried out a systematic study of...

Clinical Trials [1437 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Lilly's Emotional and Physical Symptoms of Depression Study

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Companies [1473 Associated Companies listed on BioPortfolio]

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

More Information about "Lilly Corporate Center" on BioPortfolio

We have published hundreds of Lilly Corporate Center news stories on BioPortfolio along with dozens of Lilly Corporate Center Clinical Trials and PubMed Articles about Lilly Corporate Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lilly Corporate Center Companies in our database. You can also find out about relevant Lilly Corporate Center Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record